期刊文献+

PDGF-D抗体对体外破骨前体细胞分化过程影响的相关研究 被引量:3

Effect of platelet-derived growth factor-D antibody on differentiation and maturation of osteoclasts in vitro
下载PDF
导出
摘要 目的:用外源性血小板衍生生长因子-D抗体(Platelet-derived growth factor D antibody,PDGF-DAb)体外刺激外周血单核细胞(Peripheral blood mononuclear cells,PBMCs),观察其对破骨前体细胞分化过程的影响。方法:采集血并分离单个核细胞,将所得细胞分为三组:诱导组(PDGF-D+PBMCs)、阻断组(PDGF-D+PDGF-D Ab)和对照组(细胞培养基+PBMCs)。于第15天应用抗酒石酸酸性磷酸酶(Tartrate resistant acid phosphatase,TRAP)染色和骨吸收实验观察破骨样细胞(Osteoclastlike cells,OLCs)的分化及活性;Real-time PCR检测OLCs标志基因TRAP、Cathepsin K、MMP-9(Matrix metalloproteinases 9)mR-NA的表达;Western blot检测各组细胞中Cathepsin K蛋白的表达;酶联免疫吸附试验(ELISA)检测各组细胞上清液中MMP-9的表达。结果:TRAP染色和骨吸收实验见诱导组有大量具有骨吸收功能的OLCs,而阻断组和对照组均未见。阻断组和对照组TRAP、Cathepsin K、MMP-9 mRNA的相对表达量均显著低于诱导组(P<0.05),且二组间无显著差异(P>0.05)。对照组和阻断组中Cathepsin K蛋白(Western blot检测)和MMP-9(ELISA检测)表达均低于诱导组(P<0.05),且两组间无显著差异(P>0.05)。结论:外源性PDGF-D抗体可阻断由PDGF-D诱导的PBMCs向OLCs分化过程。 Objective:To study the effects of PDGF-D Ab on the differentiation and maturation of osteoclasts(OCs) in vitro.Methods: Peripheral blood mononuclear cells(PBMCs) were gathered and isolated from the fresh blood,and then they were divided into three groups: The induction group(IG): PBMCs were induced by using PDGF-D.The control group(CG):PBMCs were threated with nothing but culture medium.The blocking group(BG): PBMCs were threated by using PDGF-D and PDGF-D antibody.At day 15,mRNA levels of tartate-resistant acid phosphatase(TRAP),matrix metalloproteinases 9(MMP-9) and Cathepsin K were detected by Real-time PCR.The differentiation and maturation of OCs were judged by TRAP staining and the function of osteoclasts by bone resorption test.The expression of Cathepsin K were detected by Western blot and the protein expression level of MMP-9 were detected by ELISA.Results: The OC-like cells were detected and showed in TRAP staining test and bone resorption test in IG,but there was no one detected in CG and BG.mRNA levels of TRAP,MMP-9,Cathepsin K at day 15 were higher in IG than those in the CG and BG(P0.05),and at the same time,there was no different between CG and BG(P0.05).As the same as the up results,the protein expression levels of MMP-9(ELISA) and Cathepsin K(Western blot) were higher in IG(P0.05),but there were no diffrences between CG and BG(P0.05).Conclusion: OC-like cells induced by PDGF-D with PBMCs could be blocked by PDGF-D antibody in vitro.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2013年第7期681-685,共5页 Chinese Journal of Immunology
基金 国家自然科学基金面上项目(No.81271979)
关键词 PDGF-D PDGF-DAb OLCs PBMCS PDGF-D PDGF-D Ab OLCs PBMCs
  • 相关文献

参考文献3

二级参考文献80

  • 1Jia L, Wei W, Cao J, et al. Silencing CD147 inhibits tumor progres- sion and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells[J]. Ann Hematol, 2009, 88(8) : 753 -760.
  • 2Jia J, Wang C, Shi Z, et al. Inhibitory effect of CD147/HAb18 mono- clonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis[ J]. Rheumatology ( Oxford), 2009, 48 (7) : 721 -726.
  • 3Schmidt R, Bultmann A, Fische! S, et al. Extracellular matrix metal- loproteinase inducer (CD147) is a novel receptor on platelets, acti- vates platelets, and augments nuclear factor kappaB-dependent inflam- mation in monocytes[J]. Circ Res, 2008, 102(3) : 302 -309.
  • 4Sato T, Ota T, Watanabe M, et al. Identification of an active site of EMMPRIN for the augmentation of matrix metalloproteinase-1 and -3 expression in a co-culture of human uterine cervical carcinoma cells and fibroblasts[J]. Gynecol Oncol, 2009, 114(2) : 337 -342.
  • 5Roodman G D. Mechanisms of bone metastasis [ J ]. N Engl J Med, 2004, 350(16) : 1655 - 1664.
  • 6Schlege| J, Redzic J S, Porter C C, et al. Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A[J]. J Mol Biol, 2009, 391(3) : 518 -535.
  • 7Li Y, Xu J, Chen L, et al. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection[J]. Histopathology, 2009, 54 (6) : 677 - 687.
  • 8Krane S M, Inada M. Matrix metalloproteinases and bone[J]. Bone, 2008, 43(1): 7-18.
  • 9Ng K W. Future developments in osteoporosis therapy [ J ]. Endocr Metab Immune Disord Drug Targets, 2009, 9(4) : 371 -384.
  • 10Mundy G R. Metastasis to bone : causes, consequences and therapeutic opportunities[J]. Nat Rev Cancer, 2002, 2(8): 584-593.

共引文献58

同被引文献29

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [ J ]. CACancer J Clin ,2013,63 : 11-30.
  • 2Sterling JA, Edwards JR, Martin TJ, et al. Adances in the biology of bone metastasis : How the skeleton affects tumor behavior[ J ]. Bone, 2011,48( 1 ) :6-15.
  • 3Loftus LS, Edwards-Bennett S, Sokol GH. Systemic therapy for bone metastases[ Jl. Cancer Control,2012,19 : 145-153.
  • 4Kung AW,Xiao SM, Cherny S,et al. Association of JAG1 with bone mineral density and osteoporotic fractures : a genome-wide association study and follow-up replication studies [ J ]. Am J Hum Genet, 2010,86 : 229 -239.
  • 5Kawatani M, Osada H. Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases [ J ]. Cancer Sci,2009,100 : 1999-2005.
  • 6Zhang XH, Wang Q, Gerald W, et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals [ J ]. Cancer Cell ,2009,16:67-78.
  • 7Timmerman LA, Grego-Bessa J, Raya A, et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation [ J ]. Genes Dev ,2004,18:99-115.
  • 8Balint K, Xiao M, Pinnix CC, et al. Activation of Notchl signaling is required for beta-eatenin-mediated human primary melanoma progression[ J]. J Clin Invest,2005,115:3166-3176.
  • 9Bedogni B,Warneke JA,Nickoloff BJ,et al. Notchl is an effector of Akt and hypoxia in melanoma development [ J ]. J Clin Invest,2008, 118:3660-3670.
  • 10Wang Z, Banerjee S, Li Y, et al. Down-regulation of notch-I inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells[ J]. Cancer Res,2006 ,66 :2778-2784.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部